Voraxaze (BTG International Inc.)


Welcome to the PulseAid listing for the Voraxaze drug offered from BTG International Inc.. This Carboxypeptidase [EPC],Carboxypeptidases [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: BTG International Inc.
NON-PROPRIETARY NAME: glucarpidase
SUBSTANCE NAME: GLUCARPIDASE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Carboxypeptidase [EPC],Carboxypeptidases [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2012-04-01
END MARKETING DATE: 0000-00-00


Voraxaze HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVoraxaze from BTG International Inc.
LABELER NAME: BTG International Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1000([USP’U]/1)
START MARKETING DATE: 2012-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50633-210_2645decc-fcc7-48ab-a217-029dcd6d8ccc
PRODUCT NDC: 50633-210
APPLICATION NUMBER: BLA125327

Other GLUCARPIDASE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BTG International Inc.Voraxaze